Search clinical trials for: Peginterferon Lambda-1A
Total 1168 results
-
Stanford UniversityCompleted
-
Bristol-Myers SquibbCompletedHepatitis CArgentina, Australia, Belgium, France, Germany, Italy, United States, Canada, Spain, Mexico, Austria, Poland, Netherlands, Korea, Republic of, Puerto Rico, New Zealand, Finland, Greece, Romania
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Bristol-Myers SquibbCompletedChronic Hepatitis C Virus Infection | Chronic Hepatitis B Virus InfectionUnited States
-
Eiger BioPharmaceuticalsActive, not recruitingHepatitis Delta VirusUnited States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
-
Icahn School of Medicine at Mount SinaiEiger BioPharmaceuticalsWithdrawnSARS-CoV-2
-
Johns Hopkins UniversityEiger BioPharmaceuticalsTerminatedSars-CoV-2 InfectionUnited States
-
Bristol-Myers SquibbCompletedHepatitis C VirusBelgium, Germany, Spain, United States, Canada, Brazil, Austria, France, Israel, Switzerland, Italy, Russian Federation, Czechia, Poland, United Kingdom
-
University Health Network, TorontoMichael Garron HospitalCompletedCovid-19 | Sars-CoV2Canada, Brazil
-
University Health Network, TorontoActive, not recruitingCovid19 | Sars-CoV2Canada
-
Bristol-Myers SquibbCompletedHepatitis C Virus (HCV)Mexico, Korea, Republic of, Czech Republic
-
BiogenCompleted
-
Bristol-Myers SquibbCompletedHepatitis CFrance, Germany, Italy, Japan, Korea, Republic of, Russian Federation, Taiwan, United Kingdom, United States, Spain, Israel, Argentina, Poland
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Completed
-
Biosplice Therapeutics, Inc.Completed
-
National Institute of Diabetes and Digestive and...Not yet recruitingChronic Hepatitis DeltaUnited States
-
BiogenCompleted
-
Pontificia Universidad Catolica de ChileTelethon Kids InstituteCompletedCovid19 | SARS-CoV Infection | InterferonChile
-
BiogenCompletedMultiple Sclerosis | HealthyUnited States
-
BiogenCompleted
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States, Italy, Switzerland, Canada, Australia, Germany, Spain, France, Portugal, Netherlands, United Kingdom, Denmark, Austria, Ireland
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
Xiamen Amoytop Biotech Co., Ltd.Peking University People's HospitalCompletedChronic Hepatitis CChina
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingSpain, Germany, Croatia, Turkey, Saudi Arabia, Hungary, Belgium, Australia, France, Portugal, Slovakia, United States, Bulgaria, Greece, Kuwait, Russian Federation, Tunisia, Italy, Argentina, Czechia, Israel, Serbia
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedHealthy Subjects | Pharmacokinetics | PharmacodynamicsUnited States
-
BiocadCompletedHepatitis | Hepatitis C | Hepatitis C/ Human Immunodeficiency Virus CoinfectionRussian Federation
-
Soroka University Medical CenterActive, not recruiting
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
BiogenWithdrawnRelapsing Multiple Sclerosis
-
Xiamen Amoytop Biotech Co., Ltd.Peking University First HospitalCompletedChronic Hepatitis BChina
-
BiogenAMS Advanced Medical Services GmbHCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Bristol-Myers SquibbTerminatedChronic Hepatitis C InfectionFrance, Germany, United States, Spain, Canada, Argentina, Mexico, Belgium, Italy, Russian Federation, United Kingdom, Poland
-
Xiamen Amoytop Biotech Co., Ltd.Peking University First HospitalCompletedChronic Hepatitis BChina
-
Valneva Austria GmbHRecruitingZika | Zika Virus InfectionUnited States
-
BiogenTerminatedMultiple Sclerosis, Relapsing-RemittingMexico, Turkey, United States, Hungary, Taiwan, Thailand, Korea, Republic of, Saudi Arabia, Malaysia, Colombia, Estonia, Jordan, Tunisia
-
Raymond ChungEiger BioPharmaceuticalsTerminated
-
BiogenCompletedMultiple Sclerosis | Exposure During PregnancySpain, Italy, Australia, Poland, United Kingdom, United States, Canada, France, Germany, Ireland
-
BiocadCompletedHepatitis | Hepatitis CBelarus, Russian Federation, India, Thailand
-
ZymoGeneticsCompletedHepatitis C, ChronicUnited States, Canada
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene FusionChina
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
Xiamen Amoytop Biotech Co., Ltd.Peking University First HospitalCompleted
-
Queen's UniversityGlaxoSmithKlineCompleted
-
BiogenCompleted
-
Boryung Pharmaceutical Co., LtdCompletedEssential Hypertension | Primary HypercholesterolemiaKorea, Republic of
-
Third Affiliated Hospital, Sun Yat-Sen UniversityPeking University; Huazhong University of Science and Technology; First People... and other collaboratorsUnknown
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
Third Affiliated Hospital, Sun Yat-Sen UniversityPeking University; Huazhong University of Science and Technology; First People... and other collaboratorsUnknownChronic Hepatitis BChina